Make an Appointment:
Call Cancer Connect at (860) 972-6000
Please have the following information available when you call:
- Results of biopsies, x-rays, or other diagnostic studies you have had
- Information about any prior treatments you have had
- Your primary medical insurance information
A Leader in Diagnosing and Treating Leukemia, Lymphoma and Multiple Myeloma
Cure and survival rates are improving significantly for hematologic cancers including Leukemia, Lymphoma and Multiple Myeloma. Hartford Hospital offers patients leading-edge research and nationally-recognized hematopatholgy expertise. With experienced oncology nurses, friendly laboratory technicians and convenient infusion services, we deliver compassionate care in a community hospital setting. With improved medications and new medical technologies, we are expanding treatment possibilities for patients with hematologic cancers – sometimes even managing these cancers as chronic illnesses.
A Multidisciplinary Team of Experts
The Helen & Harry Gray Cancer Center takes a multidisciplinary approach to treating hematologic cancers. Our treatment team includes hematologists and medical oncologists with outstanding expertise. Hospitals throughout New England call upon our experts to assist with diagnosis and special studies including immunohistochemistry, flow cytometry to determine tumor aggressiveness, and molecular genetics. We’re now researching mutations that reveal the mechanism of how these diseases start, and using this information to guide treatments.
Patients get every resource and specialist they need from a multidisciplinary team of experts lead by a hematologic oncologist. Patients and their families are considered part of the team, which also includes their primary care physician, medical oncologists, radiologists and radiation oncologists as well as our dedicated oncology nurses. An even broader group of experienced cancer specialists at the Helen & Harry Gray Cancer Center Tumor Board consults on particularly challenging cases.
The Newest Cancer Treatments
Targeted therapies such as monoclonal antibodies and radiolabelled antibodies have dramatically advanced the treatment of Leukemia, Lymphoma and improved the prognosis for Multiple Myeloma. New white cell growth inhibitors minimize risk of infection, and our infusion center collaborates with lab technicians to provide same-day red blood cell transfusions. These therapies are used in conjunction with traditional external beam radiation and improved, less toxic chemotherapies. With better anti-emetic medications and complementary therapies like Reiki and acupuncture, we help patients manage treatment side effects. With the newer, less toxic drugs now available, we can treat many patients that could not previously tolerate treatment. Sophisticated molecular biology testing at Hartford Hospital finds helpful mutation information that identifies targets of treatment for illnesses like CML. Our team is supported by excellent infectious disease specialists who help us keep immuno-supressed patients as healthy as possible.
Comfortable On-Site Infusion and Fast Laboratory Results
Most patients will receive outpatient treatment for Lymphoma or Multiple Myeloma. Patients may have private or group infusion rooms and are treated by hematologic oncology nurses certified by the Oncology Nursing Society. Many of them have been with Hartford Hospital for a decade - or even two. They offer extraordinary experience and compassion in delivering efficient and professional infusion treatments.
Patients are always kept well informed of blood test results and receive most scan results within 24 hours. Patients on cumadin therapy are closely monitored and doses are adjusted immediately to avoid potential blood clots. Our on-site pharmacy makes infusion treatments as efficient as possible for patients.